Advertisement
Screener

Callan Capital, LLC Last Quarter Change: USA Stocks, Unchanged

Callan Capital, LLC quarter change: USA Stocks, Unchanged

In share positions in stocks (listed in the US), from the quarter ended 2024-12-31 to 2025-03-31, Callan Capital, LLC opened 29 positions, added to 146, reduced 28, sold out of 15 and left 8 unchanged. The largest increase in value was PRMB (+$5,167,592); the largest decrease was META (-$22,591,052).

  • IIPR: Country of operation United States; Class COM; Shares 2024-12-31 14,590; Shares 2025-03-31 14,590.
  • CRDF: Country of operation United States; Class COM; Shares 2024-12-31 101,575; Shares 2025-03-31 101,575.
  • IAU: Country of operation United States; Class ISHARES NEW; Shares 2024-12-31 9,195; Shares 2025-03-31 9,195.
  • INGN: Country of operation United States; Class COM; Shares 2024-12-31 20,111; Shares 2025-03-31 20,111.

Two Form 13F-HR filings compared (SEC CIK 1542166): 2024-12-31 (filed 2025-02-03) and 2025-03-31 (filed 2025-04-29). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.

StockCountry of operationClassShares 2024-12-31Shares 2025-03-31Share changeValue 2024-12-31Value 2025-03-31Value change
IIPR
INNOVATIVE INDL PPTYS INC
United StatesCOM14,59014,5900$972,278$789,173-$183,105
CRDF
CARDIFF ONCOLOGY INC
United StatesCOM101,575101,5750$440,836$318,946-$121,890
IAU
ISHARES GOLD TR
United StatesISHARES NEW9,1959,1950$455,244$542,137+$86,893
INGN
INOGEN INC
United StatesCOM20,11120,1110$184,418$143,391-$41,027
EQ
EQUILLIUM INC
United StatesCOM99,68899,6880$74,587$39,108-$35,479
EPD
ENTERPRISE PRODS PARTNERS L
United StatesCOM7,7117,7110$241,817$263,254+$21,437
ALLO
ALLOGENE THERAPEUTICS INC
United StatesCOM21,08921,0890$44,920$30,790-$14,130
IBRX
IMMUNITYBIO INC
United StatesCOM12,05512,0550$30,861$36,286+$5,425

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet